Research, innovation, and expert insights from Monash Health made the headlines this week following the successful results from a global trial co-led by Professor Stephen Nicholls, Director of Victorian Heart Hospital.

The trial, in which 14,000 people participated across 32 countries, determined that a new drug, bempedoic acid, can lower cholesterol levels without side effects.

Congratulations to all those involved in the breakthrough trial and research! You can catch up on the coverage and headlines below:

Print media

• The Herald Sun – Study finds alternative to statins, led by director of new Victorian Heart Hospital at Monash Health | Sunday 5 March 2023
• The Herald Sun – Pill Heart Hope / Aussies can take heart | Sunday 5 March 2023, p.1-2

TV coverage

• Watch the ABC News coverage on their website: ABC News – New drug promises to reduce cholesterol without side effects | Sunday 5 March 2023
• Watch the 9News Melbourne coverage on Twitter: 9News Melbourne – Bempedoic acid, Nexletol: Statins alternatives for high cholesterol could be on the way | Sunday 5 March 2023
• Watch the 9News national coverage on their website: 9News – Bempedoic acid, Nexletol: Statins alternatives for high cholesterol could be on the way | Sunday 5 March 2023
• Watch the 10 News First national coverage on Vimeo: 10 News First – Cholesterol breakthrough | Sunday 5 March 2023
• Watch The Project coverage on YouTube: The Project – New Cholesterol Medication Lessens Risks Of Deadly Side Effects | Sunday 5 March 2023
• Watch the 7News Melbourne coverage on Vimeo: 7NEWS Melbourne – Miracle drug | Sunday 5 March 2023
• Watch the 7News national coverage on YouTube: 7NEWS – Magic cholesterol pill – promising to improve the lives of Australians | Sunday 5 March 2023
• Watch the Sunrise interview with Professor Stephen Nicholls on Vimeo: Sunrise – Revolutionary new pill – drug set to help Australian patients with high cholesterol | Monday 6 March 2023

Approved by Louise Kanis, Executive Director, Communication and Engagement